P. Cook

Indomethacin-induced intestinal lesions in the rat.

G. E. Dagle, D. A. Brodie, P. Cook, 1970, Toxicology and applied pharmacology.

Nicotine-induced weight loss in rats without an effect on appetite.

M. Schechter, P. Cook, M. D. Schechter, 1976, European journal of pharmacology.

Effect of New Synthetic Analogs of Somatostatin on Gastric Secretion in the Chronic Fistula Dog

C. A. Stone, M. Torchiana, P. Cook, 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effects of α2‐agonists upon colonic propulsion

R. Pendleton, P. Cook, R. Bendesky, 1986 .

A model of gastric emptying in cats shows solid emptying is promoted by MK-329: a CCK antagonist.

R. Gould, H. Solomon, P. Cook, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats

P. Cook, M. D. Schechter, 1975, Psychopharmacologia.

Effects of H2-receptor antagonists upon physiological acid secretory states in animals.

A. Mangel, R. Pendleton, P. Cook, 1985, The Journal of pharmacology and experimental therapeutics.

Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.

M. Torchiana, B. Clineschmidt, R. Pendleton, 1983, Archives internationales de pharmacodynamie et de therapie.

Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1-piperidinomethyl)phenoxy]propyl) amino-4-amino-1,2,5-thiadiazole-1-oxide (L-643, 441).

M. Torchiana, B. Clineschmidt, R. Pendleton, 1983, The Journal of pharmacology and experimental therapeutics.

Intestinal Bacteria and the Initiation of Cancer

B. Drasar, P. Cook, 1986 .

Comparison of central gastric antisecretory effects of desmethylimipramine, doxepin and pirenzepine in rats

M. Williams, C. Chung, R. Pendleton, 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.